Infectious and scarring complication following a well-performed operation but in a patient treated with anti TNF alpha (Humira®), even though it had been stopped 6 weeks previously
These immunosuppressive treatments are increasingly used to treat dysimmune diseases, and must be stopped before surgery with a delay that depends on the half-life of the product